Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways
Theranostics · 2025
DOI: 10.7150/thno.112649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Junyue Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Y…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Mitophagy, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
- Guangzhou Key Laboratory of Medical Nanomaterials, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Foshan 528200, P. R. China.
- Cellular and Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
- Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
- Department of Orthopedics and Department of Sports Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
Zitieren
APA
Fang, J., Xu, R., Cao, Y., Zhao, Z., Li, W., Lin, L., Hou, J., Xu, X., & Saw, P. E. (2025). Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways. Theranostics. https://doi.org/10.7150/thno.112649
Vancouver
Fang J, Xu R, Cao Y, Zhao Z, Li W, Lin L, et al. Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways. Theranostics. 2025. doi:10.7150/thno.112649
BibTeX
@article{Fang2025,
author = {Fang, Junyue and Xu, Rui and Cao, Yuan and Zhao, Zixuan and Li, Weifan and Lin, Li and Hou, Jingyi and Xu, Xiaoding and Saw, Phei Er},
title = {Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.112649}
}
EUVIMED